Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-169P (RNA, U7 Small Nuclear 169 Pseudogene) is a human pseudogene located on chromosome 12 and listed under the HGNC symbol 45703[3][7]. Pseudogenes are genomic sequences similar to known genes but carry disabling mutations that prevent protein or functional RNA production[4][2]. Unlike its functional counterpart RNU7-1—which is a critical component of the U7 small nuclear ribonucleoprotein (snRNP) complex involved in histone pre-mRNA processing—RNU7-169P does not encode an active RNA molecule and is not involved in known biological processes[1][7]. There are currently no drugs, disease associations, or regulatory data implicating RNU7-169P in human pathophysiology or as a marker for therapeutic intervention[7]. While some pseudogenes are increasingly recognized for their potential regulatory RNA roles, either affecting parental gene expression or acting as decoys for microRNAs[2], there is no specific annotation or research supporting such a function for RNU7-169P. Its classification as a pseudogene is supported by major genetic databases and biotype guidelines, indicating it contains mutations or disruptions that render it nonfunctional[4][7]. RNU7-169P is a canonical pseudogene—accurately named and nonfunctional—with no current evidence of biological or therapeutic targeting potential, drug interaction, or biomarker status[7]. Any structured data extraction should reflect its status as a genomic pseudogene, not a therapeutic or functional target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 Small Nuclear 169 Pseudogene (RNU7-169P).